Scenario 1 Ive just been asked to manage
Scenario 1 I’ve just been asked to manage a vendor relationship for my organization. To date, it’s not clear what is in place for the meeting and I’m not sure what the desired outcome of the meeting is. Tools: • See Section A of the Patient Technology Vendor and Sponsor Engagement Considerations for general tips on how to develop objectives for a successful meeting. See Define the “Why” • Also, visit Section B to help to determine the content of the agenda based on the “Why”. Copyright © 2020 Trans. Celerate Bio. Pharma Inc. , All rights reserved. 1
Scenario 2 I believe I have effective meetings with our vendors but I’m not sure how others in my organization manage vendor relationships. Tools: Review Section C of the Patient Technology Vendor and Sponsor Engagement Considerations around sharing best practices and learnings. Copyright © 2020 Trans. Celerate Bio. Pharma Inc. , All rights reserved. 2
Scenario 3 We would like to implement a patient facing technology into our clinical trial, but we are now determining which of the technologies may work best for our patient population. Tools: Refer to Patient Considerations, especially around pages 5 -6 where it discusses end user design – this may help ask the right questions in choosing which technology may work best for your patients. Copyright © 2020 Trans. Celerate Bio. Pharma Inc. , All rights reserved. 3
Scenario 4 We are struggling to have patients participate in a clinical trial using our technology. How can we address this? Tools: Refer to Patient Considerations – Take into account Patient Consent and Comprehension. Were these questions originally considered? Can you make adjustments now to improve your participation? Copyright © 2020 Trans. Celerate Bio. Pharma Inc. , All rights reserved. 4
Scenario 5 We are having issues in getting patients to comply with our technology. How can we address this? Tools: Refer to Patient Considerations – Patient Compliance (Pages 3 & 4) – Utilize these considerations or questions to help you identify current compliance issues to be addressed. You may also want to consider using the Patient Technology Site Feedback Questionnaire (PTSFQ) for questions to ask sites regarding compliance. Copyright © 2020 Trans. Celerate Bio. Pharma Inc. , All rights reserved. 5
Scenario 6 Can we utilize a patient technology in a new indication? What patient technology can we utilize? Tools: Refer to the Implementation Framework to aid in developing the strategy for identifying, piloting, assessing and launching the right patient facing technologies. You may also reference the Patient Considerations to get the patient’s voice in designing/adhering to the potential technology. Copyright © 2020 Trans. Celerate Bio. Pharma Inc. , All rights reserved. 6
Scenario 7 We have selected a new patient technology that we are looking to bring on; however, we are unsure how to begin the dialog with the vendor. Tools: Refer to the Vendor Infographic, which will give you context on the point of view of the vendor and how to begin developing an effective relationship. You can also explore the Vendor & Sponsor Engagement Considerations to assist you in setting up ongoing meetings with the vendor. Copyright © 2020 Trans. Celerate Bio. Pharma Inc. , All rights reserved. 7
- Slides: 7